Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

228 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study.
West MJ, Nestel PJ, Kirby AC, Schnabel R, Sullivan D, Simes RJ, Pollicino C, Lubos E, Münzel TF, White HD, Tonkin AM, Bickel C, Tiret L, Blankenberg S; LIPID Study Investigators. West MJ, et al. Among authors: bickel c. Eur Heart J. 2008 Apr;29(7):923-31. doi: 10.1093/eurheartj/ehn007. Epub 2008 Feb 22. Eur Heart J. 2008. PMID: 18296678
Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study.
Schnabel R, Rupprecht HJ, Lackner KJ, Lubos E, Bickel C, Meyer J, Münzel T, Cambien F, Tiret L, Blankenberg S; AtheroGene Investigators. Schnabel R, et al. Among authors: bickel c. Eur Heart J. 2005 Feb;26(3):241-9. doi: 10.1093/eurheartj/ehi036. Epub 2004 Nov 30. Eur Heart J. 2005. PMID: 15618051
Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene study.
Sinning JM, Bickel C, Messow CM, Schnabel R, Lubos E, Rupprecht HJ, Espinola-Klein C, Lackner KJ, Tiret L, Münzel T, Blankenberg S; AtheroGene Investigators. Sinning JM, et al. Among authors: bickel c. Eur Heart J. 2006 Dec;27(24):2962-8. doi: 10.1093/eurheartj/ehl362. Epub 2006 Nov 28. Eur Heart J. 2006. PMID: 17132649
Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study.
Keller T, Messow CM, Lubos E, Nicaud V, Wild PS, Rupprecht HJ, Bickel C, Tzikas S, Peetz D, Lackner KJ, Tiret L, Münzel TF, Blankenberg S, Schnabel RB. Keller T, et al. Among authors: bickel c. Eur Heart J. 2009 Feb;30(3):314-20. doi: 10.1093/eurheartj/ehn598. Epub 2009 Jan 19. Eur Heart J. 2009. PMID: 19153178
Multiple marker approach to risk stratification in patients with stable coronary artery disease.
Schnabel RB, Schulz A, Messow CM, Lubos E, Wild PS, Zeller T, Sinning CR, Rupprecht HJ, Bickel C, Peetz D, Cambien F, Kempf T, Wollert KC, Benjamin EJ, Lackner KJ, Münzel TF, Tiret L, Vasan RS, Blankenberg S. Schnabel RB, et al. Among authors: bickel c. Eur Heart J. 2010 Dec;31(24):3024-31. doi: 10.1093/eurheartj/ehq322. Epub 2010 Sep 18. Eur Heart J. 2010. PMID: 20852293
Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study.
Schnabel R, Blankenberg S, Lubos E, Lackner KJ, Rupprecht HJ, Espinola-Klein C, Jachmann N, Post F, Peetz D, Bickel C, Cambien F, Tiret L, Münzel T. Schnabel R, et al. Among authors: bickel c. Circ Res. 2005 Sep 2;97(5):e53-9. doi: 10.1161/01.RES.0000181286.44222.61. Epub 2005 Aug 11. Circ Res. 2005. PMID: 16100045
228 results